311 related articles for article (PubMed ID: 19281226)
1. Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.
Burns MR; Graminski GF; Weeks RS; Chen Y; O'Brien TG
J Med Chem; 2009 Apr; 52(7):1983-93. PubMed ID: 19281226
[TBL] [Abstract][Full Text] [Related]
2. Amino acid/spermine conjugates: polyamine amides as potent spermidine uptake inhibitors.
Burns MR; Carlson CL; Vanderwerf SM; Ziemer JR; Weeks RS; Cai F; Webb HK; Graminski GF
J Med Chem; 2001 Oct; 44(22):3632-44. PubMed ID: 11606128
[TBL] [Abstract][Full Text] [Related]
3. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
[TBL] [Abstract][Full Text] [Related]
5. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047.
Murray-Stewart T; Ferrari E; Xie Y; Yu F; Marton LJ; Oupicky D; Casero RA
PLoS One; 2017; 12(4):e0175917. PubMed ID: 28423064
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of bis-spermine dimers that are potent polyamine transport inhibitors.
Graminski GF; Carlson CL; Ziemer JR; Cai F; Vermeulen NM; Vanderwerf SM; Burns MR
Bioorg Med Chem Lett; 2002 Jan; 12(1):35-40. PubMed ID: 11738568
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
9. Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer.
Gitto SB; Pandey V; Oyer JL; Copik AJ; Hogan FC; Phanstiel O; Altomare DA
Mol Pharm; 2018 Feb; 15(2):369-376. PubMed ID: 29299930
[TBL] [Abstract][Full Text] [Related]
10. Targeting the polyamine transport system with benzazepine- and azepine-polyamine conjugates.
Tomasi S; Renault J; Martin B; Duhieu S; Cerec V; Le Roch M; Uriac P; Delcros JG
J Med Chem; 2010 Nov; 53(21):7647-63. PubMed ID: 20925391
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells.
Schipper RG; Deli G; Deloyer P; Lange WP; Schalken JA; Verhofstad AA
Prostate; 2000 Sep; 44(4):313-21. PubMed ID: 10951496
[TBL] [Abstract][Full Text] [Related]
12. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
13. Regulation of polyamine transport by polyamines and polyamine analogs.
Kramer DL; Miller JT; Bergeron RJ; Khomutov R; Khomutov A; Porter CW
J Cell Physiol; 1993 May; 155(2):399-407. PubMed ID: 8482732
[TBL] [Abstract][Full Text] [Related]
14. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
15. Slowing proliferation in head and neck tumors: in vitro growth inhibitory effects of the polyamine analog BE-4-4-4-4 in human squamous cell carcinomas.
Harari PM; Pickart MA; Contreras L; Petereit DG; Basu HS; Marton LJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):687-94. PubMed ID: 7790255
[TBL] [Abstract][Full Text] [Related]
16. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport.
He Y; Suzuki T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 1994 Aug; 203(1):608-14. PubMed ID: 8074711
[TBL] [Abstract][Full Text] [Related]
17. Polyamine transport inhibitors: design, synthesis, and combination therapies with difluoromethylornithine.
Muth A; Madan M; Archer JJ; Ocampo N; Rodriguez L; Phanstiel O
J Med Chem; 2014 Jan; 57(2):348-63. PubMed ID: 24405276
[TBL] [Abstract][Full Text] [Related]
18. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
19. Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.
Akinyele O; Wallace HM
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067619
[TBL] [Abstract][Full Text] [Related]
20. Unforeseen Possibilities To Investigate the Regulation of Polyamine Metabolism Revealed by Novel C-Methylated Spermine Derivatives.
Khomutov M; Hyvönen MT; Simonian A; Formanovsky AA; Mikhura IV; Chizhov AO; Kochetkov SN; Alhonen L; Vepsäläinen J; Keinänen TA; Khomutov AR
J Med Chem; 2019 Dec; 62(24):11335-11347. PubMed ID: 31765147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
